Ingraalys
French tech company | Builders Republic
About
Early-stage biotech spun out of Montpellier public research, working on cellular reprogramming — producing differentiated and rejuvenated cells from reprogrammed ones to study and reverse cellular aging, targeting applications in cell therapy and the cosmetics and skincare industry.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2017
- City
- MONTPELLIER
- Region
- Occitanie
- Tracked rounds
- 1
- Amount raised
- 0.3 M€ raised since 2020
Funding rounds
- Seed — 2024
Investors
- SATT AxLR